Many of you may already have learned of the recent death of Dr. Jay Katz. For those who were not aware, here is a link to the PRIM&R website which contains several memorial tributes.
It is difficult to put into words the impact that Katz had on the field of bioethics generally, and research ethics [...]
Who should have the final say regarding access to experimental medicines: the doctor, the patient or the FDA? This question was addressed on October 24th at a well-attended Bioethics for Breakfast session on Access to Experimental Treatments and the Indiana Courts. Rafat Abonour, MD, Director of the IU Simon Cancer Center Adult Clinical Research Office [...]
